The mechanism was put on display in HF nondiabetic mice, which is also associated with the inhibition of the cardiac nuclear-binding domain-like receptor 3 (NLRP3) inflammasome, making it a possible target for gene therapy [79]. Here, NLRP3 is linked to hydrops fetalis.